The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies
Open accessAbstract
Over the last years, the relevance of the matrix metalloproteinase (MMP) family in cancer research has grown considerably. These enzymes were initially associated with the invasive properties of tumour cells, owing to their ability to degrade all major protein components of the extracellular matrix (ECM) and basement membranes. However, further studies have demonstrated the implication of MMPs in early steps of tumour evolution, including stimulation of cell proliferation and modulation of angiogenesis. The establishment of causal relationships between MMP overproduction in tumour or stromal cells and cancer progression has prompted the development of clinical trials with a series of inhibitors designed to block the proteolytic activity of these enzymes. Unfortunately, the results derived from using broad-spectrum MMP inhibitors (MMPIs) for treating patients with advanced cancer have been disappointing in most cases. There are several putative explanations for the lack of success of these MMPIs including the recent finding that some MMPs may play a paradoxical protective role in tumour progression. These observations together with the identification of novel functions for MMPs in early stages of cancer have made necessary a reformulation of MMP inhibition strategies. A better understanding of the functional complexity of this proteolytic system and global approaches to identify the relevant MMPs which must be targeted in each individual cancer patient, will be necessary to clarify whether MMP inhibition may be part of future therapies against cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Koul, D., Parthasarathy, R. V., Shen, R., Davies, M. A., Jasser, S. A., Chintala, S. K., Rao, J. S., Sun, Y., Benvenisite, E. N., Liu, T.-J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204799 · Cited by 115
RetractedLlano, E., Pendás, A. M., Aza-Blanc, P., Kornberg, T. B., & López-Otı́n, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006045200 · Cited by 104
RetractedCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Taking Cell-Matrix Adhesions to the Third Dimension
Cukierman, E., Pankov, R., Stevens, D. R., & Yamada, K. M. (2001) · Science · doi:10.1126/science.1064829 · Cited by 3,027
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,551
Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal, B. B., Kumar, A. J., & Bharti, A. C. (2003) · PubMed · Cited by 2,550
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,908
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Regulation of matrix metalloproteinase expression in tumor invasion
Westermarck, J., & Kähäri, V. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.781 · Cited by 1,494
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Compensation mechanism in tumor cell migration
Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U. H., Deryugina, E. I., Strongin, A. Y., Bröcker, E.-B., & Friedl, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209006 · Cited by 1,391
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Self-citationCOLLAGENOLYTIC ACTIVITY IN AMPHIBIAN TISSUES: A TISSUE CULTURE ASSAY
Gross, J., & Lapiere, C. M. (1962) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.48.6.1014 · Cited by 1,310
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Matrix metalloproteinases: effectors of development and normal physiology
Vu, T. H., & Werb, Z. (2000) · Genes & Development · doi:10.1101/gad.815400 · Cited by 1,235
Furin at the cutting edge: From protein traffic to embryogenesis and disease
Thomas, G. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm934 · Cited by 1,216
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Baker, A. H., Edwards, D. R., & Murphy, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.00063 · Cited by 1,179
Activation mechanisms of matrix metalloproteinases.
Nagase, H. (1997) · PubMed · Cited by 1,119
Matrix metalloproteinases: a tail of a frog that became a prince
Brinckerhoff, C. E., & Matrisian, L. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm763 · Cited by 1,105
Role of tissue stroma in cancer cell invasion
De Wever, O., & Mareel, M. (2003) · The Journal of Pathology · doi:10.1002/path.1398 · Cited by 1,042
S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death
Gu, Z., Kaul, M., Yan, B., Kridel, S. J., Cui, J., Strongin, A., Smith, J. W., Liddington, R. C., & Lipton, S. A. (2002) · Science · doi:10.1126/science.1073634 · Cited by 950
Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)
Van den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (2002) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230290771546 · Cited by 946
Human and mouse proteases: a comparative genomic approach
Puente, X. S., Sánchez, L. M., Overall, C. M., & López-Otín, C. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1111 · Cited by 943
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Inflammation Dampened by Gelatinase A Cleavage of Monocyte Chemoattractant Protein-3
McQuibban, G. A., Gong, J.-H., Tam, E. M., McCulloch, C. A. G., Clark-Lewis, I., & Overall, C. M. (2000) · Science · doi:10.1126/science.289.5482.1202 · Cited by 772
Li, Q., Park, P. W., Wilson, C. L., & Parks, W. C. (2002) · Cell · doi:10.1016/s0092-8674(02)01079-6 · Cited by 752
Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R. M., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. B., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00597-9 · Cited by 728
Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins
Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., & Weiss, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81768-7 · Cited by 712
Hotary, K. B., Allen, E. D., Brooks, P. C., Datta, N. S., Long, M. W., & Weiss, S. J. (2003) · Cell · doi:10.1016/s0092-8674(03)00513-0 · Cited by 676
Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., & Tryggvason, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060037197 · Cited by 666
Protease degradomics: A new challenge for proteomics
López-Otín, C., & Overall, C. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm858 · Cited by 664
Qi, J. H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A., & Anand-Apte, B. (2003) · Nature Medicine · doi:10.1038/nm846 · Cited by 658
Overall, C. M., Wrana, J. L., & Sodek, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94267-5 · Cited by 636
Furin-dependent intracellular activation of the human stromelysin-3 zymogen
Pei, D., & Weiss, S. J. (1995) · Nature · doi:10.1038/375244a0 · Cited by 629
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-R¨th, F.-X., Maskos, K., Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N., Nagase, H., Brew, K., Bourenkov, G. P., et al. (1997) · Nature · doi:10.1038/37995 · Cited by 619
The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen Matrix
Pilcher, B. K., Dumin, J. A., Sudbeck, B. D., Krane, S. M., Welgus, H. G., & Parks, W. C. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.6.1445 · Cited by 612
Curry, T. E., & Osteen, K. G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0005 · Cited by 609
Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J. C., Maeshima, Y., Yang, C., Hynes, R. O., Werb, Z., Sudhakar, A., & Kalluri, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00133-8 · Cited by 559
Structure of Human Pro-Matrix Metalloproteinase-2: Activation Mechanism Revealed
Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., & Tryggvason, K. (1999) · Science · doi:10.1126/science.284.5420.1667 · Cited by 540
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice
Balbín, M., Fueyo, A., Tester, A. M., Pendás, A. M., Pitiot, A. S., Astudillo, A., Overall, C. M., Shapiro, S. D., & López-Otín, C. (2003) · Nature Genetics · doi:10.1038/ng1249 · Cited by 536
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Mareel, M., & Leroy, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00024.2002 · Cited by 524
Bond, M., Fabunmi, R. P., Baker, A. H., & Newby, A. C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01034-5 · Cited by 512
TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)
Kashiwagi, M., Tortorella, M., Nagase, H., & Brew, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000848200 · Cited by 509
TIMP-2 Mediated Inhibition of Angiogenesis
Seo, D.-W., Li, H., Guedez, L., Wingfield, P. T., Diaz, T., Salloum, R., Wei, B.-Y., & Stetler-Stevenson, W. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00551-8 · Cited by 508
Complex roles of tissue inhibitors of metalloproteinases in cancer
Jiang, Y., Goldberg, I. D., & Shi, Y. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205291 · Cited by 507
Overall, C. M. (2002) · Molecular Biotechnology · doi:10.1385/mb:22:1:051 · Cited by 504
Rodríguez-Manzaneque, J. C., Lane, T. F., Ortega, M. A., Hynes, R. O., Lawler, J., & Iruela-Arispe, M. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171460498 · Cited by 473
Matrix metalloproteinases as mediators of reproductive function
Hulboy, D. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.1.27 · Cited by 460
Plasmin and Matrix Metalloproteinases in Vascular Remodeling
Lijnen, H. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616230 · Cited by 453
Antisense RNA-Induced Reduction in Murine TIMP Levels Confers Oncogenicity on Swiss 3T3 Cells
Khokha, R., Waterhouse, P., Yagel, S., Lala, P. K., Overall, C. M., Norton, G., & Denhardt, D. T. (1989) · Science · doi:10.1126/science.2465572 · Cited by 451
Matrix Metalloproteinases Generate Angiostatin: Effects on Neovascularization
Cornelius, L. A., Nehring, L. C., Harding, E., Bolanowski, M., Welgus, H. G., Kobayashi, D. K., Pierce, R. A., & Shapiro, S. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6845 · Cited by 444
Bramhall, S. R., Rosemurgy, A., Brown, P. D., Bowry, C., Buckels, J. A. C., & for the Marimastat Pancreatic Cancer Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3447 · Cited by 438
Vázquez, F., Hastings, G., Ortega, M.-A., Lane, T. F., Oikemus, S., Lombardo, M., & Iruela-Arispe, M. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23349 · Cited by 426
Shishodia, S., Majumdar, S., Banerjee, S., & Aggarwal, B. B. (2003) · PubMed · Cited by 426
Powell, W. C., Fingleton, B., Wilson, C. L., Boothby, M., & Matrisian, L. M. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80113-x · Cited by 424
Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion
Seiki, M. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00699-7 · Cited by 406
The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3
Amour, A., Knight, C. G., Webster, A., Slocombe, P. M., Stephens, P. E., Knäuper, V., Docherty, A. J. P., & Murphy, G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01528-3 · Cited by 404
Generation and degradation of human endostatin proteins by various proteinases
Ferreras, M., Felbor, U., Lenhard, T., Olsen, B. R., & Delaissé, J.-M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02249-3 · Cited by 377
Mitsiades, N., Yu, W., Poulaki, V., Tsokos, M., & Stamenkovic, I. (2001) · PubMed · Cited by 365
Huang, S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.15.1134 · Cited by 349
Kim, Y. M., Jang, J.-W., Lee, O., Yeon, J.-H., Choi, E.-Y., Kim, K., Lee, S., & Kwon, Y. (2000) · PubMed · Cited by 347
Alexander, C. M., Hansell, E. J., Behrendtsen, O., Flannery, M. L., Kishnani, N. S., Hawkes, S. P., & Werb, Z. (1996) · Development · doi:10.1242/dev.122.6.1723 · Cited by 338
Adipocyte Produces Matrix Metalloproteinases 2 and 9
Bouloumié, A., Sengenès, C., Portolan, G., Galitzky, J., & Lafontan, M. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2080 · Cited by 329
Regulation of Membrane Type-1 Matrix Metalloproteinase Activation by Proprotein Convertases
Yana, I., & Weiss, S. J. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.7.2387 · Cited by 322
Belotti, D., Paganoni, P., Manenti, L., Garofalo, A., Marchini, S., Taraboletti, G., & Giavazzi, R. (2003) · PubMed · Cited by 318
New Functions for Non-collagenous Domains of Human Collagen Type IV
Petitclerc, E., Boutaud, A., Prestayko, A., Xu, J., Sado, Y., Ninomiya, Y., Sarras, M. P., Hudson, B. G., & Brooks, P. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.8051 · Cited by 315
Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.
Lal, A., Glazer, C. A., Martinson, H. M., Friedman, H. S., Archer, G. E., Sampson, J. H., & Riggins, G. J. (2002) · PubMed · Cited by 311
Matrix metalloproteinases in cancer
Itoh, Y., & Nagase, H. (2002) · Essays in Biochemistry · doi:10.1042/bse0380021 · Cited by 309
Sgadari, C., Barillari, G., Toschi, E., Carlei, D., Bacigalupo, I., Baccarini, S., Palladino, C., Leone, P., Bugarini, R., Malavasi, L., et al. (2002) · Nature Medicine · doi:10.1038/nm0302-225 · Cited by 309
Wiseman, B. S., Sternlicht, M. D., Lund, L. R., Alexander, C. M., Mott, J., Bissell, M. J., Soloway, P., Itohara, S., & Werb, Z. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302090 · Cited by 303
Yang, Z., Strickland, D. K., & Bornstein, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008925200 · Cited by 297
Mohan, R., Sivak, J., Ashton, P., Russo, L. A., Pham, B. Q., Kasahara, N., Raizman, M. B., & Fini, M. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10405 · Cited by 274
Lohi, J., Wilson, C. L., Roby, J. D., & Parks, W. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m001599200 · Cited by 273
Functional overlap between two classes of matrix-degrading proteases in wound healing
Lund, L. R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4645 · Cited by 270
A novel role of metalloproteinase in cancer-mediated immunosuppression.
Sheu, B., Hsu, S.-M., Ho, H., Lien, H., Huang, S., & Lin, R. H. (2001) · PubMed · Cited by 268
Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial
Bramhall, S. R., Hallissey, M. T., Whiting, J., Scholefield, J., Tierney, G., Stuart, R. C., Hawkins, R. E., McCulloch, P., Maughan, T., Brown, P. D., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600310 · Cited by 265
Sounni, N. E., Devy, L., Hajitou, A., Frankenne, F., Munaut, C., Gilles, C., Deroanne, C., Thompson, E. W., Foidart, J. M., & Noel, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0790com · Cited by 260
Thrombospondin Type 1 Repeats Interact with Matrix Metalloproteinase 2
Bein, K., & Simons, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003834200 · Cited by 255
Page-McCaw, A., Serano, J., Santé, J. M., & Rubin, G. M. (2003) · Developmental Cell · doi:10.1016/s1534-5807(02)00400-8 · Cited by 254
Gálvez, B. G., Matı́as-Román, S., Albar, J. P., Sánchez-Madrid, F., & Arroyo, A. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104094200 · Cited by 251
Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development
Hojilla, C. V., Mohammed, F. F., & Khokha, R. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601327 · Cited by 246
Johansson, N., Ala-aho, R., Uitto, V.-J., Grénman, R., Fusenig, N. E., López-OtÍn, C., & Kähäri, V.-M. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.2.227 · Cited by 243
Mansour, A. M., Drevs, J., Esser, N., Hamada, F. M. A., Badary, O. A., Unger, C., Fichtner, I., & Kratz, F. (2003) · PubMed · Cited by 239
Herman, M. P., Sukhova, G. K., Kisiel, W., Foster, D., Kehry, M. R., Libby, P., & Schönbeck, U. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10403 · Cited by 236
Simon, C., Goepfert, H., & Boyd, D. (1998) · PubMed · Cited by 235
Velasco, G., Pendás, A. M., Fueyo, A., Knäuper, V., Murphy, G., & López-Otı́n, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4570 · Cited by 234
Impaired Wound Contraction in Stromelysin-1–Deficient Mice
Bullard, K. M., Lund, L., Mudgett, J. S., Mellin, T. N., Hunt, T. K., Murphy, B., Ronan, J., Werb, Z., & Banda, M. J. (1999) · Annals of Surgery · doi:10.1097/00000658-199908000-00017 · Cited by 231
Groves, M. D., Puduvalli, V. K., Hess, K. R., Jaeckle, K. A., Peterson, P., Yung, W. K. A., & Levin, V. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1383 · Cited by 229
Zhu, Y. Y., Spitz, M. R., Lei, L., Mills, G. B., & Wu, X. (2001) · PubMed · Cited by 226
Reunanen, N., Li, S.-P., Ahonen, M., Foschi, M., Han, J., & Kähäri, V.-M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204296200 · Cited by 221
Woo, J.-H., Lim, J. H., Kim, Y.-H., Suh, S.-I., Min, D. S., Chang, J.-S., Lee, Y. H., Park, J.-W., & Kwon, T. K. (2004) · Oncogene · doi:10.1038/sj.onc.1207307 · Cited by 213
Takada, Y., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3278 · Cited by 212
Hua, J., & Muschel, R. J. (1996) · PubMed · Cited by 211
Nemunaitis, J. J., Poole, C. J., Primrose, J. M., et al. (1998) · PubMed · Cited by 211
Mañes, S., Mira, E., Barbacid, M. D. M., Ciprés, A., Fernández-Resa, P., Buesa, J. M., Mérida, I., Aracil, M., Márquez, G., & Martı́nez-A, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25706 · Cited by 210
Pavlaki, M., & Zucker, S. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023047431869 · Cited by 209
Uría, J. A., & López-Otín, C. (2000) · PubMed · Cited by 206
Stromelysin-1 Regulates Adipogenesis during Mammary Gland Involution
Alexander, C. M., Selvarajan, S., Mudgett, J., & Werb, Z. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.4.693 · Cited by 206
Liu, L., Chang, H., Chiang, L., & Hung, W. (2003) · PubMed · Cited by 203
Membrane type-matrix metalloproteinases (MT-MMP)
Zucker, S., Pei, D., Cao, J., & Lopez-Otin, C. (2003) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(03)54004-2 · Cited by 200
Self-citationStructural Analysis and Promoter Characterization of the Human Collagenase-3 Gene (MMP13)
Pendás, A. M., Balbı́n, M., Llano, E., Jiménez, M. G., & López-Otı́n, C. (1997) · Genomics · doi:10.1006/geno.1996.4554 · Cited by 200
Urı́a, J. A., Jiménez, M. G., Balbı́n, M., Freije, J. M. P., & López-Otı́n, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9769 · Cited by 194
MMP‐2 and MMP‐9 synergize in promoting choroidal neovascularization
Lambert, V., Wielockx, B., Munaut, C., Galopin, C., Jost, M., Itoh, T., Werb, Z., Baker, A., Libert, C., Krell, H.-W., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0113fje · Cited by 189
Cellular Activation of MMP-2 (Gelatinase A) by MT2-MMP Occurs via a TIMP-2-independent Pathway
Morrison, C. J., Butler, G. S., Bigg, H. F., Roberts, C. R., Soloway, P. D., & Overall, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108643200 · Cited by 180
Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP)
Williamson, R. A., Marston, F. A. O., Angal, S., Koklitis, P., Panico, M., Morris, H. R., Carne, A. F., Smith, B. J., Harris, T. J. R., & Freedman, R. B. (1990) · Biochemical Journal · doi:10.1042/bj2680267 · Cited by 179
Crawford, H. C., Fingleton, B., Gustavson, M. D., Kurpios, N., Wagenaar, R. A., Hassell, J. A., & Matrisian, L. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1370-1383.2001 · Cited by 175
McGaha, T. L., Bona, C., Phelps, R. G., & Spiera, H. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01690.x · Cited by 170
Wielockx, B., Lannoy, K., Shapiro, S. D., Itoh, T., Itohara, S., Vandekerckhove, J., & Libert, C. (2001) · Nature Medicine · doi:10.1038/nm1101-1202 · Cited by 167
Pei, D., Kang, T., & Qi, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006493200 · Cited by 167
AP-1--glucocorticoid receptor crosstalk taken to a higher level
Karin, M., & Chang, L. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690447 · Cited by 167
Nyberg, P., Heikkilä, P., Sorsa, T., Luostarinen, J., Heljasvaara, R., Stenman, U.-H., Pihlajaniemi, T., & Salo, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210325200 · Cited by 166
Annabi, B., Lachambre, M.-P., Bousquet-Gagnon, N., Pagé, M., Gingras, D., & Béliveau, R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00187-2 · Cited by 165
Matrix Metalloproteinases and Tumor Progression
Freije, J. M. P., Balbín, M., Pendás, A. M., Sánchez, L. M., Puente, X. S., & López-Otín, C. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0081-0_9 · Cited by 160
Kondraganti, S. R., Mohanam, S., Chintala, S. K., Kin, Y., Jasti, S. L., Nirmala, C., Lakka, S. S., Adachi, Y., Kyritsis, A. P., Ali‐Osman, F., et al. (2000) · PubMed · Cited by 160
Bassi, D., de Cicco, R. L., Mahloogi, H., Zucker, S., Thomas, G., & Klein–Szanto, A. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191199198 · Cited by 157
Cianfrocca, M. E., Cooley, T. P., Lee, J., Rudek, M. A., Scadden, D. T., Ratner, L., Pluda, J. M., Figg, W. D., Krown, S. E., & Dezube, B. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.153 · Cited by 156
Bannikov, G. A., Karelina, T. V., Collier, I. E., Marmer, B. L., & Goldberg, G. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110931200 · Cited by 154
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
Pozzi, A., LeVine, W. F., & Gardner, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205045 · Cited by 154
Sato, T., Koike, L., Miyata, Y., Hirata, M., Mimaki, Y., Sashida, Y., Yano, M., & Itô, A. (2002) · PubMed · Cited by 154
Ma, Z., Qin, H., & Benveniste, E. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5150 · Cited by 152
Mott, J. D., Thomas‐Virnig, C. L., Rosenbach, M. T., Takahara, K., Greenspan, D. S., & Banda, M. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1384 · Cited by 152
Tam, E. M., Wu, Y., Butler, G. S., Stack, M. S., & Overall, C. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206874200 · Cited by 144
Nakada, M., Yamada, A. Y., Takino, T., Miyamori, H., Takahashi, T., Yamashita, J., & Sato, H. (2001) · PubMed · Cited by 144
Collagenase 2 (MMP-8) Expression in Murine Tissue-remodeling Processes
Balbı́n, M., Fueyo, A., Knäuper, V., Pendás, A. M., López, J. M., Jiménez, M., Murphy, G., & López-Otı́n, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23959 · Cited by 141
Ny, T., Wahlberg, P., & Brändström, I. J. M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00711-0 · Cited by 141
Yu, C.-Y., Pan, K., Xing, D., Liang, G., Tan, W., Zhang, L., & Lin, D. (2002) · PubMed · Cited by 136
Ueda, J., Kajita, M., Suenaga, N., Fujii, K., & Seiki, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206962 · Cited by 136
Nielsen, B. S., Rank, F. E., López, J. M., Balbín, M., Vizoso, F. J., Lund, L. R., Danø, K., & López-Otín, C. (2001) · PubMed · Cited by 135
Protease inhibitors: Role and potential therapeutic use in human cancer
DeClerck, Y. A., & Imren, S. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00460-m · Cited by 135
Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang, J., Fizazi, K. S., Peleg, S., Sikes, C. R., Raymond, A. K., Jamal, N., Hu, M. C. ‐., Olivé, M., Martinez, L. A., Wood, C. G., et al. (2001) · PubMed · Cited by 131
Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin.
Liu, S., Netzel–Arnett, S., Birkedal‐Hansen, H., & Leppla, S. H. (2000) · PubMed · Cited by 128
Boulay, A., Masson, R., Chenard, M., Fahime, E. E., Cassard, L., Bellocq, J., Sautès‐Fridman, C., Basset, P., & Rio, M. C. (2001) · PubMed · Cited by 127
Sancéau, J., Truchet, S., & Bauvois, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304300200 · Cited by 123
Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials
Falardeau, P., Champagne, P., Poyet, P., Hariton, C., & Dupont, �. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90035-1 · Cited by 123
Rudolph‐Owen, L. A., Hulboy, D. L., Wilson, C. L., Mudgett, J. S., & Matrisian, L. M. (1997) · Endocrinology · doi:10.1210/en.138.11.4902 · Cited by 121
Jiang, Y., Wang, M., Celiker, M., Liu, Y., Sang, Q., Goldberg, I. D., & Shi, Y. E. (2001) · PubMed · Cited by 119
Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis
Sounni, N. E., Janssen, M., Foidart, J., & Noël, A. (2003) · Matrix Biology · doi:10.1016/s0945-053x(03)00003-9 · Cited by 119
Witty, J. P., Lempka, T., Coffey, R. J., & Matrisian, L. M. (1995) · PubMed · Cited by 117
Miao, X., Yu, C.-Y., Tan, W., Xiong, P., Liang, G., Lu, W., & Lin, D. (2003) · PubMed · Cited by 116
Endostatin binds to the catalytic domain of matrix metalloproteinase‐2
Lee, S., Jang, J.-W., Kim, Y.-M., Lee, H. I., Jeon, J. Y., Kwon, Y., & Lee, S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02742-4 · Cited by 116
Jiménez, M. J. G., Balbín, M., Álvarez, J., Komori, T., Bianco, P., Holmbeck, K., Birkedal‐Hansen, H., López, J. M., & López-Otín, C. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200106147 · Cited by 114
Fenrick, R., Wang, L., Nip, J., Amann, J. M., Rooney, R. J., Walker‐Daniels, J., Crawford, H. C., Hulboy, D. L., Kinch, M. S., Matrisian, L. M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5828-5839.2000 · Cited by 110
Pan, M., & Hung, W.-C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202334200 · Cited by 103
Llano, E., Adam, G., Pendás, A. M., Quesada, V., Sánchez, L. M., Santamarı́a, I., Noselli, S., & López-Otı́n, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200121200 · Cited by 100
Sun, Y., Cheung, J. M., Martel‐Pelletier, J., Pelletier, J. P., Wenger, L., Altman, R. D., Howell, D. S., & Cheung, H. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11327 · Cited by 97
London, C. A., Sekhon, H. S., Arora, V., Stein, D. A., Iversen, P. L., & Devi, G. R. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700642 · Cited by 95
Tanimura, S., Asato, K., Fujishiro, S., & Kohno, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00670-3 · Cited by 92
Lockhart, A. C., Braun, R. D., Yu, D., et al. (2003) · PubMed · Cited by 90
Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Andarawewa, K. L., Boulay, A., Masson, R., Mathelin, C., Stoll, I., Tomasetto, C., Chenard, M., Gintz, M., Bellocq, J., & Rio, M. (2003) · PubMed · Cited by 88
Altered Tumor Growth and Metastasis of a T-Cell Lymphoma in Timp-1 Transgenic Mice
Krüger, A., Fata, J. E., & Khokha, R. (1997) · Blood · doi:10.1182/blood.v90.5.1993 · Cited by 82
Kataoka, H., Uchino, H., Iwamura, T., Seiki, M., Nabeshima, K., & Koono, M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65292-3 · Cited by 82
Zhang, Y., Thant, A. A., Machida, K., Ichigotani, Y., Naito, Y., Hiraiwa, Y., Senga, T., Sohara, Y., Matsuda, S., & Hamaguchi, M. (2002) · PubMed · Cited by 76
Lee, M., Rapti, M., & Murphy, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305678200 · Cited by 73
A functional overlap of plasminogen and MMPs regulates vascularization during placental development
Solberg, H., Rinkenberger, J. L., Danø, K., Werb, Z., & Lund, L. R. (2003) · Development · doi:10.1242/dev.00642 · Cited by 72
Severely Impaired Wound Healing in the Collagenase-Resistant Mouse
Beare, A. H. M., O’Kane, S., Ferguson, M. W. J., & Krane, S. M. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12019.x · Cited by 68
Martin, D. C., Sanchez-Sweatman, O. H., Ho, A. T. V., Inderdeo, D. S., Tsao, M., & Khokha, R. (1999) · PubMed · Cited by 68
Peng, K.-W., Vile, R. G., Cosset, F., & Russell, S. J. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300982 · Cited by 66
Slaton, J. W., Karashima, T., Perrotte, P., Inoue, K., Kim, S. J., Izawa, J. I., Kedar, D. J., McConkey, D. J., Millikan, R. E., Sweeney, P., et al. (2001) · PubMed · Cited by 63
Nie, J., & Pei, D. (2003) · PubMed · Cited by 57
Zacchigna, S., Zentilin, L., Morini, M., Dell’Eva, R., Noonan, D. M., Albini, A., & Giacca, M. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700657 · Cited by 57
Fra‐1 targets the AP‐1 site/2G single nucleotide polymorphism (ETS site) in the MMP‐1 promoter
Tower, G. B., Coon, C. I., Belguise, K., et al. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03821.x · Cited by 52
Stromelysin-3 Induction and Interstitial Collagenase Repression by Retinoic Acid
Guérin, É., Ludwig, M., Basset, P., & Anglard, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11088 · Cited by 50
Lacerna, L. V., & Hohneker, J. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.017 · Cited by 43
Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases
Schneider, R. M., Medvedovska, Y., Hartl, I., Voelker, B. T., Chadwick, M. P., Russell, S. J., Cichutek, K., & Buchholz, C. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302007 · Cited by 41
Woo, J.-H., Park, J. W., Lee, S.-H., Kim, Y.-H., Lee, I. K., Gabrielson, E., Lee, S., Lee, H.-J., Kho, Y., & Kwon, T. K. (2003) · PubMed · Cited by 38
Amin, A. R. M. R., Oo, M. L., Senga, T., Suzuki, N., Feng, G., & Hamaguchi, M. (2003) · PubMed · Cited by 37
Kuga, H., Morisaki, T., Nakamura, K., Onishi, H., Noshirο, H., Uchiyama, A., Tanaka, M., & Katano, M. (2003) · Oncogene · doi:10.1038/sj.onc.1207046 · Cited by 32
Futamura, M., Kamiya, S., Tsukamoto, M., Hirano, A., Monden, Y., Arakawa, H., & Nishimura, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204878 · Cited by 16
Interleukin-2-collagen chimeric protein which liberates interleukin-2 upon collagenolysis
Hayashi, M., Tomita, M., & Yoshizato, K. (2002) · Protein Engineering Design and Selection · doi:10.1093/protein/15.5.429 · Cited by 10
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Matrix Metalloproteinases in Cancer
Fingleton, B., & Matrisian, L. M. (2001) · doi:10.1007/978-1-59259-011-7_4 · Cited by 4
Cited by
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
Matrix metalloproteinases and tumor metastasis
Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
Jabłońska-Trypuć, A., Matejczyk, M., & Rosochacki, S. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1161620 · Cited by 1,042
Brain metastases: epidemiology and pathophysiology
Gavrilovic, I. T., & Posner, J. B. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-8093-6 · Cited by 975
Metadata
- Authors
- Folgueras, A. R., Pendas, A. M., Sanchez, L. M., & Lopez-Otin, C.
- Venue
- The International Journal of Developmental Biology
- Publisher
- EHU Press
- Published
- 2004
- Volume
- 48
- Issue
- 5-6
- Pages
- 411-424
- ISSN
- 0214-6282 (ISSN-L)
- OpenAlex
- W1990858735
- Cited by
- 590
- References
- 181
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.